AGT and triple-A syndrome: A small murine AAA study inducing AAA by angiotensin II by subcutaneously implanted osmotic mini pumps has examined stem cell-based treatment on already formed AAA at day 28 [24] rather than in the acute phase at day 0 or 1 post-surgery in the PPE-AAA model.